Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

Last Close
Jan 22  •  03:07PM ET
53.12
Dollar change
+3.31
Percentage change
6.65
%
Jan 21, 1:01 PMModerna-Merck cancer vaccine's five-year data showing 49% reduced recurrence risk fueled the sharp intraday rally.
IndexS&P 500 P/E- EPS (ttm)-8.06 Insider Own8.54% Shs Outstand391.00M Perf Week30.90%
Market Cap20.76B Forward P/E- EPS next Y-6.73 Insider Trans-0.07% Shs Float357.38M Perf Month57.16%
Enterprise Value16.98B PEG- EPS next Q-2.58 Inst Own69.82% Short Float19.12% Perf Quarter93.23%
Income-3.12B P/S9.30 EPS this Y14.29% Inst Trans-3.98% Short Ratio5.89 Perf Half Y53.22%
Sales2.23B P/B2.23 EPS next Y15.37% ROA-22.31% Short Interest68.32M Perf YTD80.13%
Book/sh23.86 P/C4.61 EPS next 5Y20.42% ROE-29.32% 52W High50.00 6.24% Perf Year48.01%
Cash/sh11.53 P/FCF- EPS past 3/5Y- -42.94% ROIC-31.11% 52W Low22.28 138.42% Perf 3Y-72.14%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-43.99% 121.86% Gross Margin38.93% Volatility7.38% 6.79% Perf 5Y-59.05%
Dividend TTM- EV/Sales7.61 EPS Y/Y TTM-38.95% Oper. Margin-155.15% ATR (14)2.74 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.73 Sales Y/Y TTM-56.00% Profit Margin-139.61% RSI (14)83.42 Recom2.96
Dividend Gr. 3/5Y- - Current Ratio3.93 EPS Q/Q-1673.01% SMA2045.30% Beta1.27 Target Price36.58
Payout- Debt/Eq0.08 Sales Q/Q-45.44% SMA5072.52% Rel Volume2.72 Prev Close49.81
Employees5800 LT Debt/Eq0.07 EarningsNov 06 BMO SMA20089.89% Avg Volume11.59M Price53.12
IPODec 07, 2018 Option/ShortYes / Yes EPS/Sales Surpr.72.79% 10.33% Trades Volume27,486,129 Change6.65%
Date Action Analyst Rating Change Price Target Change
Jan-07-26Resumed UBS Neutral $34
Dec-12-25Initiated Jefferies Hold $30
Mar-13-25Initiated Citigroup Neutral $40
Feb-18-25Downgrade Barclays Overweight → Equal Weight $111 → $45
Jan-29-25Downgrade Goldman Buy → Neutral $99 → $51
Dec-18-24Downgrade Argus Buy → Hold
Dec-10-24Resumed BofA Securities Underperform $41
Nov-19-24Initiated Berenberg Hold $42
Nov-18-24Upgrade HSBC Securities Hold → Buy $58
Nov-15-24Initiated Wolfe Research Underperform $40
Today 02:31PM
02:08PM
01:01PM
12:27PM
11:39AM
10:51AM Loading…
10:51AM
10:11AM
09:31AM
08:08AM
06:27AM
06:22AM
06:17AM
05:47AM
05:19AM
03:38AM
01:03AM Loading…
01:03AM
12:01AM
Jan-21-26 08:23PM
07:32PM
07:11PM
04:46PM
03:57PM
02:24PM
01:57PM
12:21PM
10:06AM
05:38AM
Jan-20-26 06:00PM
04:21PM
03:31PM
10:24AM Loading…
10:24AM
06:58AM
06:00AM
Jan-18-26 11:35PM
08:31AM
Jan-17-26 04:30AM
Jan-16-26 12:45PM
08:55AM
08:06AM
07:07AM
03:56AM
Jan-15-26 08:53AM
08:26AM
Jan-14-26 05:50PM
07:09AM
04:04AM
Jan-13-26 08:21PM
06:18PM
04:43PM
04:35PM
04:30PM
04:27PM
02:57PM
02:24PM
01:26PM
01:04PM
Jan-12-26 05:14PM
11:27AM
10:24AM
08:51AM
07:00AM
Jan-08-26 05:50PM
Jan-07-26 09:26AM
08:55AM
08:04AM
04:35AM
03:58AM
Jan-06-26 11:12AM
Jan-05-26 06:44AM
Dec-30-25 05:45PM
Dec-27-25 10:30AM
Dec-26-25 02:14PM
01:53PM
12:12PM
10:25AM
10:25AM
Dec-23-25 05:45PM
Dec-22-25 08:55AM
Dec-19-25 03:16PM
10:10AM
04:30AM
Dec-18-25 01:14PM
12:32PM
11:51AM
09:54AM
07:00AM
Dec-17-25 01:01PM
07:00AM
Dec-16-25 09:55AM
03:03AM
Dec-15-25 09:05AM
07:00AM
Dec-12-25 10:47AM
09:35AM
09:13AM
Dec-11-25 02:03PM
12:50PM
07:44AM
Dec-09-25 09:36PM
11:04AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AFEYAN NOUBARDirectorDec 11 '25Option Exercise10.9023,853259,99827,777Dec 15 09:00 AM
AFEYAN NOUBARDirectorDec 11 '25Sale29.4823,853703,3063,924Dec 15 09:00 AM
Bancel StephaneChief Executive OfficerDec 11 '25Option Exercise10.90688,0737,499,9966,181,970Dec 15 08:59 AM
Flagship Pioneering Inc.AffiliateDec 11 '25Proposed Sale29.4923,853703,306Dec 11 04:30 PM
Hussain AbbasDirectorDec 09 '25Sale27.6050413,9101,515Dec 11 04:16 PM
Hussain AbbasDirectorDec 09 '25Proposed Sale27.6050413,910Dec 09 10:26 AM
Hussain AbbasDirectorJun 11 '25Sale28.003128,736580Jun 12 04:22 PM
Hussain AbbasDirectorJun 11 '25Proposed Sale28.003128,736Jun 11 10:06 AM
Bancel StephaneChief Executive OfficerMar 03 '25Buy31.22160,3145,004,3189,210,686Mar 04 04:27 PM
SAGAN PAULDirectorMar 03 '25Buy31.7631,6201,004,251312,027Mar 04 04:24 PM